SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-008661
Filing Date
2021-04-13
Accepted
2021-04-13 17:16:07
Documents
71
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 970920
2 ex31-1.htm EX-31.1 12301
3 ex32-1.htm EX-32.1 4254
4 form10-k_001.jpg GRAPHIC 15370
5 form10-k_002.jpg GRAPHIC 12735
6 symbl_001.jpg GRAPHIC 919
  Complete submission text file 0001493152-21-008661.txt   5238413

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE endv-20201231.xml EX-101.INS 865754
8 XBRL SCHEMA FILE endv-20201231.xsd EX-101.SCH 59553
9 XBRL CALCULATION FILE endv-20201231_cal.xml EX-101.CAL 55610
10 XBRL DEFINITION FILE endv-20201231_def.xml EX-101.DEF 265293
11 XBRL LABEL FILE endv-20201231_lab.xml EX-101.LAB 446673
12 XBRL PRESENTATION FILE endv-20201231_pre.xml EX-101.PRE 353515
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55453 | Film No.: 21823713
SIC: 2834 Pharmaceutical Preparations